Autologous Fat Grafting Market

Autologous Fat Grafting Market Study by Integrated Fat Transfer Systems, Aspiration & Harvesting, Liposuction, Fat Processing, and De-epithelialization Systems, from 2024 to 2034

Analysis of Autologous Fat Grafting Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Autologous Fat Grafting Market Outlook (2024 to 2034)

Worldwide revenue from the sales of autologous fat grafting solutions is approximated at US$ 200.5 million in 2024 and has been calculated to rise at a CAGR of 7.7% to reach US$ 422 million by the end of 2034.

Autologous fat grafting systems are used for precise and faster fat processing, which eliminates the use of laborious manual procedures. This makes the overall fat grafting process effective and more affordable. Autologous fat transfer systems and accessories find major application in minimal and non-invasive cosmetic procedures.

Rising awareness about cosmetic surgeries and growing demand for non-invasive procedures are contributing to the increasing demand for autologous fat grafting devices.

A comprehensive assessment of some of the major challenges and unique growth factors is analysed by Fact.MR. This edition (2024 to 2034) is set to make readers up to date with key autologous fat grafting market trends, providing analysis on how manufacturers and other stakeholders are reacting to change. The study also expands the competitive landscape section, and readers are expected to get to know the key strategies of established players as well as new companies in the market.

Fact.MR, in its revised research report, tracks the global sales of autologous fat grafting solutions in several high-growth markets, with North America and Europe being the dominant regional markets.

  • The North American autologous fat grafting market size is anticipated to reach US$ 171.6 million by 2034.
  • Western Europe is estimated to hold 21.4% of the global autologous fat grafting market share in 2024.
Report Attributes Details
Autologous Fat Grafting Market Size (2024E) US$ 200.5 Million
Forecasted Market Value (2034F) US$ 422 Million
Global Market Growth Rate (2024 to 2034) 7.7% CAGR
South Korea Market Value (2034F) US$ 17.3 Million
Aspiration & Harvesting System Demand Growth Rate (2024 to 2034) 8% CAGR
Key Companies Profiled
  • Genesis Biosystems, Inc.
  • Black Tie Medical Inc. (Tulip Medical Inc.)
  • AbbVie Inc. (Allergan plc)
  • Sisram Medical, Ltd (Alma Lasers)
  • Human Med AG.
  • Sterimedix Ltd
  • Plus Therapeutics, Inc. (Cytori Therapeutics, Inc.)
  • Proteal Bioregenerative Solutions
  • Ranfac Corp.
  • HK Surgical Inc.
  • Medikan International Inc.
  • Lipogems International SpA
  • MicroAire Surgical Instruments, LLC
  • Innovia Medical Inc.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

Which Market Dynamics are Pushing Sales of Autologous Fat Grafting Technologies?

“Rising Prevalence of Scar Contractures and Incidence of Accident and Fire Burns”

Increasing prevalence of scar contractures and growing demand for correction of contour deformities in reconstructed breasts are expected to drive demand for autologous fat grafting procedures. Patients of accidents, burns, and surgeries can develop abnormal and painful scars that may lead to the hardening or tightening of the skin, which mostly results in the limitation of motion. Unfortunately, several of these patients sustain serious scarring and life-long physical disabilities.

  • According to the American Burn Association, around 450,000 patients receive hospital and emergency room treatment for burns annually in the United States, and 96.7% of these patients suffer from serious scarring, life-long physical disabilities, and adjustment difficulties.

Most often, skin in the region of scars cannot be fully recovered even with aesthetic treatments that are currently available in the market. However, with advancements in autologous fat grafting, it is set to become possible to treat such scarring from both, an aesthetic and functional point of view. Using autologous fat grafting, the skin in the scarred region becomes softer and more flexible & extensible, and the color of the graft becomes almost the same as that of the original skin.

Patients treated with autologous fat grafting have also reported that they experienced less pain and improved scar elasticity. Improvements can be noticed as early as within two weeks.

“Favorable Reimbursement Policies Increasing Adoption of Autologous Fat Grafting Procedures”

Various healthcare and government insurance providers are offering reimbursement facilities for the diagnosis and treatment of skin burns, scars, and skin-related complications. These are covered under Medicare, Medicaid, and private health insurance plans for all healthcare services, which is contributing to overall autologous fat grafting market growth.

Several government agencies, private insurers, and other payers regulate the provision of coverage for a particular procedure and provide reimbursement to hospitals for medical treatment.

  • In United States, hospitals reimburse at a fixed rate based on the Diagnosis-related Group (DRG) established by the United States Centers for Medicare and Medicaid Services.

However, this procedure has been the most preferred choice among aesthetic specialists due to its simplicity and effectiveness. Medicare and other healthcare insurance providers in the United States are facilitating the provision of reliable autologous fat grafting treatment options.

What May Lower Adoption Rate of Autologous Fat Grafting Procedures?

“High Treatment Cost and Complications Associated with Post-Autologous Fat Grafting”

Autologous fat grafting is one of the most expensive methods, due to which, initial treatment and post-treatment cost is likely to be a financial burden for the family of a patient. Over the years, autologous fat grafting is emerging as a popular cosmetic reconstruction technique practiced by dermatologic surgeons across the world. However, common complications associated with this procedure include bleeding, tissue lumps, and scarring, among others.

Furthermore, fat grafting systems should be used with extreme caution for patients suffering from chronic medical conditions such as diabetes, heart disease, lung disease, circulatory system disease, and obesity. These types of post grafting complications affect the adoption of the process, as many patients may opt not to go ahead with the procedure.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

What Tactics Should New Companies Take to Stand Out in the Crowd?

“Focus on Innovations to Increase Market Reach”

New companies should focus on advancing their products. Advancements in autologous fat grafting technologies and devices are set to attract a wider consumer base. Rising popularity of liposuction body contouring is driving demand for advance lipografting products. In this context, new companies can also focus on niche product manufacturing and marketing.

Country-wise Analysis

The United States is anticipated to hold 84.2% of the North American market share by 2034. Sales of autologous fat grafting technologies in South Korea and India are set to increase at a healthy pace during the next 10 years.

What is Driving Demand for Autologous Fat Grafting in the United States?

“Increasing Number of Reconstruction Procedures Boosting Sales of Autologous Fat Grafting Systems”

Attribute United States
Market Value (2024E) US$ 63.3 Million
Growth Rate (2024 to 2034) 8.6% CAGR
Projected Value (2034F) US$ 144.4 Million

Growing preference for aesthetic cosmetic procedures such as autologous fat grafting in the United States is expected to support the market growth in the country.

  • According to the American Society for Aesthetic Plastic Surgery (ASAPS), around two-third of aesthetic treatments performed by plastic surgeons are nonsurgical procedures such as autologous fat transfer, which help avoid complications associated with allogeneic fillers and implants.

Similarly, increasing demand for reconstruction procedures in the United States is another major factor driving sales of plastic surgery instruments.

Why is Innovation in Autologous Fat Grafting Key to Success in the United Kingdom?

“United Kingdom Forefront in Technological Innovations in Autologous Fat Grafting”

Continued investments in product development are contributing to the commercialization of autologous fat transfer systems and accessories in the United Kingdom. Additionally, increase in research & development activities are leading to the incorporation of these products in various aesthetic procedures, for achieving faster scar and skin recovery.

Availability of technical resources and enhanced knowledge base from research collaborations tend to improve the quality of autologous fat grafting and its success rates in the United Kingdom.

Which Aspects are Increasing Demand for Autologous Fat Grafting Technologies in Japan?

“Increasing Prevalence of Aesthetic and Cosmetic Procedures”

Attribute Japan
Market Value (2024E) US$ 12.2 Million
Growth Rate (2024 to 2034) 3.2% CAGR
Projected Value (2034F) US$ 16.7 Million

Growing number of aesthetic and cosmetic procedures in Japan is expected to drive demand for autologous fat grafting in the country.

  • According to statista.com, eyelid surgeries were major cosmetic surgeries performed in Japan in 2022.

Also, growing preference for non-invasive procedures such as autologous fat grafting with minimal incisions are increasing in the country, which indicates wide growth scope for autologous fat grafting industry leaders.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Category-wise Analysis

Fact.MR, a market research and competitive intelligence provider estimates that the integrated fat transfer system sales are set to hold dominant share in the global market. This can be due to its effective end result.

Why Do Integrated Fat Transfer Systems are Widely Demanded?

“Integrated Fat Transfer Systems Aid in Rapid Recovery with Lesser Allergic Risks”

Attribute Integrated Fat Transfer Systems
Segment Value (2024E) US$ 65.4 Million
Growth Rate (2024 to 2034) 8.2% CAGR
Projected Value (2034F) US$ 143.2 Million

An integrated fat transfer system is used commercially for the aspiration, filtering, harvesting, and transferring of autologous adipose tissues or fats for aesthetic body contouring. These systems are intended to eliminate local deposits of additional fat through minor incisions, and consequently transfer the tissue back to the patient. Integrated fat transfer continues to gather adhesion as a sustainable alternative to invasive cosmetic surgery, as demand for younger skin with minimal skin invasion remains high.

Furthermore, benefits of integrated fat transfer procedures, including rapid recovery with lesser allergic risks and reduced downtime, are encouraging demand globally. Key manufacturers are focusing more on the development of integrated fat transfer systems to meet consumer demand.

How Big is the Opportunity in Breast Augmentation for Autologous Fat Grafting Product Manufacturers?

“Rising Trend to Appear Beautiful Among Women is Set to Increase Breast Augmentation Procedure Rates”

Attribute Breast Augmentation
Segment Value (2024E) US$ 84.8 Million
Growth Rate (2024 to 2034) 7.9% CAGR
Projected Value (2034F) US$ 181.2 Million

Increasing cases of breast cancer, rising prevalence of breast augmentation, and lifestyle changes are set to provide growth opportunities for autologous fat grafting providers.

Breast augmentation is one of the most popular surgeries among women across the globe. The rising trend to appear aesthetically beautiful is driving attention of females for breast implant surgeries. Some of the latest technologies include transumbilical breast augmentation and transaxillary breast augmentation.

Competitive Landscape

Some of the key players in the autologous fat grafting market include Genesis Biosystems, Inc., Black Tie Medical Inc. (Tulip Medical Inc.), AbbVie Inc. (Allergan Plc.), Sisram Medical, Ltd (Alma Lasers), Human Med AG., Plus Therapeutics, Inc. (Cytori Therapeutics, Inc.), and Sterimedix Ltd.

Leading companies are maintaining their market position by continuously innovating their product folio. They are also focusing on global expansion, acquisitions, and collaborations to boost their market reach.

  • In May 2020, AbbVie acquired Allergan Plc. to include several new products in the aesthetics and women's healthcare portfolio.

Key Segments of Autologous Fat Grafting Market Research

  • By Product :

    • Integrated Fat Transfer Systems
    • Aspiration & Harvesting Systems
    • Liposuction Systems
    • Fat Processing Systems
    • De-epithelialization Devices
    • Accessories
  • By Application :

    • Breast Augmentation
    • Buttock Augmentation
    • Facial Fat Grafting
    • Hand Rejuvenation
  • By End User :

    • Hospitals
    • On-site Clinics
    • Plastic Surgery Centers
  • By Region :

    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • Middle East & Africa

- FAQs -

What is the size of the autologous fat grafting market in 2024?

The global autologous fat grafting market is calculated at US$ 200.5 million for 2024.

How big is the CAGR of the autologous fat grafting market?

Global demand for autologous fat grafting solutions is projected to increase at a CAGR of 7.7% from 2024 to 2034.

What are the projected sales of autologous fat grafting systems for 2034?

Sales of autologous fat grafting solutions are forecasted to reach US$ 422 million by 2034.

What is the current value of the South Korea market?

The South Korea market is evaluated at US$ 8 million in 2024.

Which product type is widely popular in this market?

Integrated fat transfer systems are set to hold 33.9% of the global market share by 2034.

What are the most common facial locations for autologous fat grafting?

Eyebrows, temples, upper and lower eyelids, and tear trough are some of the common locations.

Who are the top suppliers of autologous fat grafting solutions?

Some of the leading companies include Genesis Biosystems, Inc., Ranfac Corp., MicroAire Surgical Instruments, LLC, and Innovia Medical Inc.

- Also of Interest -

Minimally Invasive Surgery Market

Minimally Invasive Surgery Market Analysis, By Procedure (Laparoscopic, Robotic Surgery, Endoscopic Mucosal Resection), By Disorder Type (Orthopedic, Cosmetic & Bariatric, Gynaecological, Cardiothoracic, Gastrointestinal, Urological), By End User and Region - Global Market Insights 2022-2032

Plastic Surgery Instruments Market

Plastic Surgery Instruments Market Analysis By Type (Handheld Instruments, Electrosurgical Instruments & Other Instruments) By Procedures (Cosmetic Surgeries & Reconstructive Surgeries) By End User and By Region – Global Market Insights 2022 to 2026

Cosmetic Surgery and Procedure Market

Cosmetic Surgery and Procedure Market Size, Share, Forecast,Trends, Growth Analysis, By Procedure (Invasive, Non-invasive), By Gender (Male, Female), By Age Group (13-29, 30-54, 55 & Above), By region - Global Market Insights 2022 to 2030

Liposuction Surgery Devices Market

Liposuction Surgery Devices Market Analysis by Product Type (Stand-alone, Portable Liposuction Surgery Devices), by Technology (Tumescent, Ultrasound-assisted, Laser-assisted, Power-assisted, Water Assisted) & Regional Forecast 2022-2032

Autologous Fat Grafting Market

Schedule a Call